Aerosol delivery of small hairpin osteopontin blocks pulmonary metastasis of breast cancer in mice

PLoS ONE

Volumn 5, Issue 12, 2010, Pages

  Yu, Kyeong Nam ^a   Minai Tehrani, Arash ^a   Chang, Seung Hee ^a   Hwang, Soon Kyung ^a   Hong, Seong Ho ^a   Kim, Ji Eun ^a,b   Shin, Ji Young ^a   Park, Sung Jin ^a   Kim, Ji Hye ^a,b   Kwon, Jung Taek ^a   Jiang, Hu Lin ^a   Kang, Bitna ^a   Kim, Duyeol ^a   Chae, Chan Hee ^a   Lee, Kee Ho ^c   Yoon, Tae Jong ^d   Beck, George R ^e   Cho, Myung Haing ^a,b  

^a Seoul National University   (South Korea)

^b Seoul National University   (South Korea)

^c Korea Institute of Radiation and Medical Science   (South Korea)

^d CHA University   (South Korea)

^e EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LENTIVIRUS VECTOR; OSTEOPONTIN; SHORT HAIRPIN RNA;

AEROSOL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GENE EXPRESSION; GENE TARGETING; LUNG METASTASIS; METASTASIS INHIBITION; MOUSE; NONHUMAN; VIRAL GENE DELIVERY SYSTEM; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; EXPERIMENTAL NEOPLASM; GENE TRANSFER; GENETICS; HUMAN; LENTIVIRINAE; LUNG TUMOR; METABOLISM; METASTASIS; PATHOLOGY; SKIN TUMOR; TREATMENT OUTCOME; TUMOR CELL LINE;

LENTIVIRUS; MURINAE; MUS;

AEROSOLS; ANIMALS; CELL LINE, TUMOR; FEMALE; GENE TRANSFER TECHNIQUES; HUMANS; LENTIVIRUS; LUNG NEOPLASMS; MAMMARY NEOPLASMS, ANIMAL; MICE; MICE, INBRED BALB C; NEOPLASM METASTASIS; OSTEOPONTIN; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 78650968903     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0015623     Document Type: Article

References (48)

1. Oates AJ, Barraclough R, Rudland PS (1997) The role of osteopontin in tumorigenesis and metastasis. Invasion Metastasis 17: 1-15.
2. Senger DR, Perruzzi CA, Papadopoulos A (1989) Elevated expression of secreted phosphoprotein I (osteopontin, 2ar) as a consequence of neoplastic transformation. Anticancer Res 9: 1291-1299.
3. Brown LF, Papadopoulos-Sergiou A, Berse B, Manseau EJ, Tognazzi K, et al. (1994) Osteopontin expression and distribution in human carcinomas. Am J Pathol 145: 610-623.
4. Denhardt DT (1996) Oncogene-initiated aberrant signaling engenders the metastatic phenotype: synergistic transcription factor interactions are targets for cancer therapy. Crit Rev Oncog 7: 261-291.
5. Chakraborty G, Jain S, Patil TV, Kundu GC (2008) Down-regulation of osteopontin attenuates breast tumour progression in vivo. Cell Mol Med 12: 2305-2318.
6. Behrend EI, Craig AM, Wilson SM, Denhardt DT, Chambers AF (1995) Expression of antisense osteopontin RNA in metastatic mouse fibroblasts is associated with reduced malignancy. Ann N Y Acad Sci 760: 299-301.
7. Behrend EI, Craig AM, Wilson SM, Denhardt DT, Chambers AF (1994) Reduced malignancy of ras-transformed NIH 3T3 cells expressing antisense osteopontin RNA. Cancer Res 54: 832-837.
8. Adwan H, Bäuerle T, Najajreh Y, Elazer V, Golomb G, et al. (2004) Decreased levels of osteopontin and bone sialoprotein II are correlated with reduced proliferation, colony formation, and migration of GFP-MDA-MB-231 cells. Int J Oncol 24: 1235-1244.
9. Singhal H, Bautista DS, Tonkin KS, O'Malley FP, Tuck AB, et al. (1997) Elevated plasma osteopontin in metastatic breast cancer associated with increased tumor burden and decreased survival. Clin Cancer Res 3: 605-611.
10. Weber GF, Lett GS, Haubein NC (2010) Osteopontin is a marker for cancer aggressiveness and patient survival. Br J Cancer 103: 861-869.
11. Solomayer EF, Diel IJ, Meyberg GC, Gollan C, Bastert G (2000) Metastatic breast cancer: clinical course, prognosis and therapy related to the first site of metastasis. Breast Cancer Res Treat 59: 271-278.
12. LeiDeng, GuoqiangLi, LisenXi, AihongYin, Yun Gao, et al. (2009) Hepatitis B virus inhibition in mice by lentiviral vector mediated short hairpin RNA. BMC Gastroenterol 9: 73-82.
13. Ohno K, Nishimori H, Yasoshima T, Kamiguchi K, Hata F, et al. (2010) Inhibition of osteopontin reduces liver metastasis of human pancreatic cancer xenografts injected into the spleen in a mouse model. Surg Today 40: 347-356.
14. Elbashir SM, Lendeckel W, Tuschl T (2001) RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev 15: 188-200.
15. Zamora-Avila DE, Zapata-Benavides P, Franco-Molina MA, Saavedra-Alonso S, Trejo-Avila LM, et al. (2009) WT1 gene silencing by aerosol delivery of PEI- RNAi complexes inhibits B16-F10 lung metastases growth. Cancer Gene Ther 16: 892-899.
16. Kim HW, Park IK, Cho CS, Lee KH, Beck GR, Jr., et al. (2004) Aerosol delivery of glucosylated polyethylenimine/phosphatase and tensin homologue deleted on chromosome 10 complex suppresses Akt downstream pathways in the lung of K-ras null mice. Cancer Res 64: 7971-7976.
17. Hwang SK, Kwon JT, Park SJ, Chang SH, Lee ES, et al. (2007) Lentivirusmediated carboxyl-terminal modulator protein gene transfection via aerosol in lungs of K-ras null mice. Gene Ther 14: 1721-1730.
18. Hwang SK, Lim HT, Minai-Tehrani A, Lee ES, Park J, et al. (2009) Repeated aerosol delivery of carboxyl-terminal modulator protein suppresses tumor in the lungs of K-rasLA1 mice. Am J Respir Crit Care Med 179: 1131-1140.
19. Rizzo P, Miao H, D'Souza G, Osipo C, Song LL, et al. (2008) Cross-talk between notch and the estrogen receptor in breast cancer suggests novel therapeutic approaches. Cancer Res 68: 5226-5235.
20. Leland P, Taguchi J, Husain SR, Kreitman RJ, Pastan I, et al. (2000) Human breast carcinoma cells express type II IL-4 receptors and are sensitive to antitumor activity of a chimeric IL-4-Pseudomonas exotoxin fusion protein in vitro and in vivo. Mol Med 6: 165-178.
21. Ravi D, Ramadas K, Mathew BS, Nalinakumari KR, Nair MK, et al. (1998) Angiogenesis during tumor progression in the oral cavity is related to reduced apoptosis and high tumor cell proliferation. Oral Oncol 34: 543-548.
22. Singh RP, Deep G, Chittezhath M, Kaur M, Dwyer-Nield LD, et al. (2006) Effect of silibinin on the growth and progression of primary lung tumors in mice. J Natl Cancer Inst 98: 846-855.
23. Keleg S, Büchler P, Ludwig R, Büchler MW, Friess H (2003) Invasion and metastasis in pancreatic cancer. Mol Cancer 22: 14-20.
24. Yu P, Huang B, Shen M, Lau C, Chan E, et al. (2001) P15(PAF), a novel PCNA associated factor with increased expression in tumor tissues. Oncogene 20: 484-489.
25. Trono D (2000) Lentiviral vectors: turning a deadly foe into a therapeutic agent. Gene Ther 7: 20-23.
26. Jatoi I, Hilsenbeck SG, Clark GM, Osborne CK (1999) Significance of axillary lymph node metastasis in primary breast cancer. J Clin Oncol 17: 2334-2340.
27. Vinh-Hung V, Verschraegen C, Promish DI, Cserni G, Van de Steene J, et al. (2004) Ratios of involved nodes in early breast cancer. Breast Cancer Res 6: 680-688.
28. Veronesi U, Paganelli G, Viale G, Galimberti V, Luini A, et al. (1999) Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series. J Natl Cancer Inst 91: 368-373.
29. Gautam A, Densmore CL, Golunski E, Xu B, Waldrep JC (2001) Transgene expression in mouse airway epithelium by aerosol gene therapy with PEI-DNA complexes. Mol Ther 3: 551-556.
30. Goula D, Becker N, Lemkine GF, Normandie P, Rodrigues J, et al. (2000) Rapid crossing of the pulmonary endothelial barrier by polyethylenimine/DNA complexes. Gene Ther 7: 499-504.
31. Lotze MT, Kost TA (2002) Viruses as gene delivery vectors: application to gene function, target validation, and assay development. Cancer Gene Ther 9: 692-699.
32. Kay MA, Glorioso JC, Naldini L (2001) Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics. Nat Med 7: 33-40.
33. Shevde LA, Das S, Clark DW, Samant RS (2010) Osteopontin: an effector and an effect of tumor metastasis. Curr Mol Med 10: 71-81.
34. Dai J, Li B, Shi J, Peng L, Zhang D, et al. (2010) A humanized anti-osteopontin antibody inhibits breast cancer growth and metastasis in vivo. Cancer Immunol Immunother 59: 355-366.
35. Toloza EM, Morse MA, Lyerly HK (2006) Gene therapy for lung cancer. J Cell Biochem 99: 1-22.
36. Denhardt DT, Guo X (1993) Osteopontin: a protein with diverse functions. FASEB J 7: 1475-1482.
37. Denhardt DT, Noda M, O'Regan AW, Pavlin D, Berman JS (2001) Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival. J Clin Invest 107: 1055-1061.
38. Paradis V, Eschwege P, Loric S, Dumas F, Ba N, et al. (1998) De novo expression of CD44 in prostate carcinoma is correlated with systemic dissemination of prostate cancer. J Clin Pathol 51: 798-802.
39. Gao YF, Li X, Xie QX, Gui SY, Wang Y, et al. (2005) Expressions of osteopontin and CD44v6 in hepatocellular carcinoma and their clinical significance. Zhonghua Gan Zang Bing Za Zhi 13: 227-228.
40. Suzuki H, Yamashiro K (2002) Reduced expression of CD44 v3 and v6 is related to invasion in lung adenocarcinoma. Lung Cancer 38: 137-141.
41. Yu P, Zhou L, Ke W, Li K (2010) Clinical significance of pAKT and CD44v6 overexpression with breast cancer. J Cancer Res Clin Oncol 136: 1283-1292.
42. Ferrara N (2004) Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev 25: 581-611.
43. Dvorak HF (2002) Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy. J Clin Oncol 20: 4368-4380.
44. Tokunaga T, Oshika Y, Abe Y, Ozeki Y, Sadahiro S, et al. (1998) Vascular endothelial growth factor (VEGF) mRNA isoform expression pattern is correlated with liver metastasis and poor prognosis in colon cancer. Br J Cancer 77: 998-1002.
45. Shijubo N, Uede T, Kon S, Nagata M, Abe S (2000) Vascular endothelial growth factor and osteopontin in tumor biology. Crit Rev Oncog 11: 135-146.
46. Akar U, Ozpolat B, Mehta K, Lopez-Berestein G, Zhang D, et al. (2010) Targeting p70S6K prevented lung metastasis in a breast cancer xenograft model. Mol Cancer Ther 9: 1180-1187.
47. Roy R, Zhang B, Moses MA (2006) Making the cut: protease-mediated regulation of angiogenesis. Exp Cell Res 312: 608-622.
48. Thaete LG, Ahnen DJ, Malkinson AM (1989) Proliferating cell nuclear antigen (PCNA/cyclin) immunocytochemistry as a labeling index in mouse lung tissues. Cell Tissue Res 256: 167-173.